VCG
ALXN

Vantage Consulting Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Vantage Consulting Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,246
Closed -$229K – 221
2021
Q2 		$229K Buy
+1,246
New +$229K 0.04% 169
2021
Q1 		– Sell
-603
Closed -$94K – 1820
2020
Q4 		$94K Buy
+603
New +$94K 0.01% 205